Growth Metrics

Core Laboratories (CLB) Total Liabilities (2022 - 2026)

Core Laboratories filings provide 5 years of Total Liabilities readings, the most recent being $318.8 million for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 4.05% to $318.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $318.8 million, a 4.05% decrease, with the full-year FY2025 number at $318.0 million, down 4.44% from a year prior.
  • Total Liabilities hit $318.8 million in Q1 2026 for Core Laboratories, roughly flat from $318.0 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $403.8 million in Q2 2022 to a low of $314.0 million in Q3 2025.
  • Median Total Liabilities over the past 5 years was $356.2 million (2024), compared with a mean of $355.8 million.
  • Biggest five-year swings in Total Liabilities: decreased 8.74% in 2025 and later fell 4.05% in 2026.
  • Core Laboratories' Total Liabilities stood at $394.8 million in 2022, then decreased by 8.31% to $362.0 million in 2023, then decreased by 8.06% to $332.8 million in 2024, then decreased by 4.44% to $318.0 million in 2025, then grew by 0.26% to $318.8 million in 2026.
  • The last three reported values for Total Liabilities were $318.8 million (Q1 2026), $318.0 million (Q4 2025), and $314.0 million (Q3 2025) per Business Quant data.